Lengthy Clinical Presentation

29
Lengthy Clinical Presentation Ellen Mattes Barbouche, MD Primary Care Conference 10 March 2004

description

Lengthy Clinical Presentation. Ellen Mattes Barbouche, MD Primary Care Conference 10 March 2004. No Funding for this Discussion. Case – Initial Presentation Day 4 of illness Provider #1. 33 year old female with 3 days of headache, nausea, fatigue, facial pressure - PowerPoint PPT Presentation

Transcript of Lengthy Clinical Presentation

Page 1: Lengthy Clinical Presentation

Lengthy Clinical Presentation

Ellen Mattes Barbouche, MD

Primary Care Conference

10 March 2004

Page 2: Lengthy Clinical Presentation

No Funding for this Discussion

Page 3: Lengthy Clinical Presentation

Case – Initial Presentation Day 4 of illness

Provider #1• 33 year old female with 3 days of headache,

nausea, fatigue, facial pressure• History of migraine with aura, mononucleosis as

teenager• Topical pimecrolimus for atopic dermatitis• Penicillin allergy, no alcohol or tobacco• Married researcher at UW Primate Center• FH: mother hypothyroidism• PE: Afebrile, injected posterior oropharynx, left-

sided, anterior cervical adenopathy, otherwise unremarkable head, neck, chest exam

Page 4: Lengthy Clinical Presentation

Initial presentation – cont’d

• Laboratory: Negative urine pregnancy

• Diagnosis: Probable recurrent sinusitis

• Treatment: Azithromycin 500 mg day 1, then 250 mg daily, days 2-5

Page 5: Lengthy Clinical Presentation

Second clinic visit – Day 15Provider #1

• No improvement with azithromycin• Continued daily (AM) headaches, some relief

with ibuprofen• PM “indigestion”• Sore throat, post-nasal drainage, myalgias,

fatigue• PE: T 99.4, pale and fatigued, left tonsillar and

anterior cervical adenopathy, otherwise normal head, neck, chest, and neurologic exams

Page 6: Lengthy Clinical Presentation

Clinic visit 2, day 15 – cont’d

• Laboratory: Normal CBC with 40% lymphocytes and normal free T4 and TSH

• Impression: Possible viral illness

• Recommendation: Discontinue ibuprofen. Acetominophen if necessary, rest, and hydrate well. Call if symptoms continue.

Page 7: Lengthy Clinical Presentation

Immediate Care/Emergency Department Visit – Day 23

Provider #3• 3 days of left leg pain after days off work to

recuperate from illness• 3 cm linear erythema and pain to palpation left

lower extremity• Diagnosis: Superficial venous thrombophlebitis• Treatment: Elevate for 48 hours with moist heat

QID, ibuprofen 400 mg TID or aspirin 325 mg QID with ranitidine 150 mg BID

• Follow up with primary MD if symptoms persist over 2 days

Page 8: Lengthy Clinical Presentation

Clinic Visit 3 – Day 29Provider #5

• Continued headache, facial pain, and low-grade fever

• Recurrent epigastric discomfort after ibuprofen for leg pain

• Immediate care visit discontinued ibuprofen, encouraged ranitidine, which helped

• PE: Afebrile. Posterior oropharyngeal erythema, no adenopathy, otherwise normal head and chest exam

Page 9: Lengthy Clinical Presentation

Clinic visit 3, day 29 – cont’d

• Laboratory: Normal CBC, although 64% lymphocytes, normal sinus films, ESR 21, ALT 256, AST 145, CRP 2, Lyme EIA 0.02

• Impression: Prolonged illness with NSAID-induced gastritis

• Follow up with primary MD

Page 10: Lengthy Clinical Presentation

Clinic visit 4, Day 31Provider #6, Primary MD

• Myalgias, fatigue, low-grade fevers persist• Headaches decreased• Post-prandial right upper quadrant abdominal

discomfort for one week• No jaundice, but “dark urine”• No acetominophen• PE: Afebrile, weight stable for 6 months, normal

funduscopic exam, no icterus, small superior, anterior adenopathy, no hepatosplenomegaly, normal neuro, heart, lung, skin exams

Page 11: Lengthy Clinical Presentation

Clinic visit #4, day 31 – cont’d

• Diagnostic test performed

Page 12: Lengthy Clinical Presentation
Page 13: Lengthy Clinical Presentation

Objectives: Review CMV in Immunocompetant Patient

• Epidemiology

• Pathology

• Laboratory features

• Clinical presentation and complications

Page 14: Lengthy Clinical Presentation

CMV spectrum of disease

• Asymptomatic to mononucleosis syndrome in normal host

• Congenital CMV syndrome frequently fatal

• Potential for much more severe disease in immunocompromised

• BMT: CMV pneumonia most common life-threatening infection

• AIDS: most common viral infectionMandell, 5th ed., 2000;1586-1596.

Page 15: Lengthy Clinical Presentation

Epidemiology

• Common, but socioeconomically determined– Developing countries near 100% during

childhood– US population

• Lower socioeconomics approach 90% CMV IgG by age 40

• Upper socioeconomics near 50% by adulthood

• Transmitted by body fluid contact

Page 16: Lengthy Clinical Presentation

CMV pathology

• Largest herpes virus to infect humans• CMV glycoproteins complex with HLA-1

molecules– Prevents recognition and destruction by CD8

lymphocytes• Nuclear inclusion cells (cytomegaly)• Allows latent infection

• Most antivirals target CMV DNA polymerase

Beersma. J Immunology. 1993;151:4455-4464.

Page 17: Lengthy Clinical Presentation

Laboratory Diagnosis of CMV

• Detection of nuclear inclusion-cells in urine sediment,saliva, blood, biopsy specimens

• Immunocompetant: IgM CMV (SLC $30)– Specificity increased by removing IgG and

rheumatoid factor prior to testing– Remains elevated < 4 months

• Immunocompromised: CMV DNA probe

Page 18: Lengthy Clinical Presentation

CMV Mononucleosis

• Classic triad of infectious mononucleosis: FEVER, LYMPHADENOPATHY, LYMPHOCYTOSIS• Hematologic hallmark of infectious mononucleosis:

>50% lymphocytes, of these >10% atypical• Of infectious mononucleosis cases, approximately 80-

90% EBV, 10-20% CMV– CMV usually heterophile agglutinin negative– CMV usually more systemic – fever, adenopathy– CMV more likely older young adults (20-35)– EBV more likely sore throat, exudative tonsils

Klemola. J Infectious Disease. 1970;121: 608-614.

Page 19: Lengthy Clinical Presentation

CMV Complications

• Hepatic– Frequent subclinical transaminitis– Rare granulomatous hepatitis

• Gastrointestinal– Inflammatory colitis– Gastritis– Esophagitis– Ileitis

Stam. J Clinical Gastroenterology. 1996;22:322.

Page 20: Lengthy Clinical Presentation

CMV Complications, cont’d

• Neurologic– Meningitis– Encephalitis– Guillain-Barre syndrome

• CMV and campylobacter most frequently identified• Younger patients• Increased sensory deficits, more frequent

respiratory insufficiency and cranial nerve impairment

• Slower recovery

Page 21: Lengthy Clinical Presentation

CMV Complications, cont’d

• Cardiovascular– Pericarditis– Myocarditis– Atherosclerosis

• Mechanism: infected vascular endothelium increased proliferation smooth muscle cells which increase oxygenated scavengers and decrease LDL uptake

• CAD risk correlates with CMV IgG titers

High. Clinical Infectious Disease.1999:28(4)746-749.

Sorlie. Archives Internal Medicine. 2000;160(13)2027-2032.

Page 22: Lengthy Clinical Presentation

CMV Complications

• Pulmonary– Pneumonitis

• Ocular– Retinitis

• Hematologic– Anemia: hemolytic – cold agglutinins– Thrombocytopenia – if infected megakaryocytes

• Rheumatologic– Frequent arthralgias, RARE arthritis– 25-35% develop positive rhematoid factor

Page 23: Lengthy Clinical Presentation

CMV Prevention

• Good hygeine

• Child and health care workers

• Immunocompromised population– Prophylaxis soon after transplant

Page 24: Lengthy Clinical Presentation

CMV during pregnancy

• Primary infection in 1-3% of U.S. pregnant women

• Most mothers asymptomatic, few mononucleosis• 2/3 infants not infected, of the remaining third,

only 10-15% symptomatic at birth• Effected fetus may develop hepatosplenomegaly

to death• 80-90% of infected infants will develop

complications within 2 years: hearing loss, visual impairment, mental retardation

cdc.gov/ncidod/diseases/cmv.htm

Page 25: Lengthy Clinical Presentation

Case follow up

• Gradual return to normal health and normal transaminases over 2.5 months

• Repeat CMV IgM fell

Page 26: Lengthy Clinical Presentation

Conclusions

• CMV may cause atypical mononucleosis syndrome

• Diagnosis– Lymphocytosis with atypical lymphs– CMV IgM level

Page 27: Lengthy Clinical Presentation
Page 28: Lengthy Clinical Presentation
Page 29: Lengthy Clinical Presentation